Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

c-Rel Antikörper (Internal Region)

Verified c-Rel Reaktivität: Human WB, ELISA, IHC Wirt: Ziege Polyclonal unconjugated
Produktnummer ABIN571133
  • Target Alle c-Rel Antikörper anzeigen
    c-Rel (REL proto-oncogene (c-Rel))
    Bindungsspezifität
    • 19
    • 9
    • 8
    • 7
    • 7
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Internal Region
    Reaktivität
    • 84
    • 23
    • 6
    • 5
    • 5
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    Human
    Wirt
    • 78
    • 10
    Ziege
    Klonalität
    • 70
    • 18
    Polyklonal
    Konjugat
    • 36
    • 9
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser c-Rel Antikörper ist unkonjugiert
    Applikation
    • 59
    • 36
    • 13
    • 13
    • 10
    • 8
    • 5
    • 4
    • 3
    • 3
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
    Verwendungszweck
    REL
    Sequenz
    NDLNASNACI YN
    Kreuzreaktivität
    Human
    Aufreinigung
    Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
    Güteklasse
    Verified
    Immunogen
    Peptide with sequence NDLNASNACIYN, from the internal region of the protein sequence according to NP_002899.1.
    Isotyp
    IgG
    Top Product
    Discover our top product c-Rel Primärantikörper
  • Applikationshinweise

    Immunohistochemistry: Paraffin embedded Human Thymus. Recommended concentration: 2.5 μg/mL.

    Western Blot: Approx 70 kDa band observed in Human Spleen and Human Peripheral Blood Mononucleocytes lysates (calculated MW of 68.5 kDa according to NP_002899.1). Recommended concentration: 0.5-2 μg/mL. Primary incubation was 1 hour.

    Peptide ELISA: antibody detection limit dilution 1:16000.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.5 mg/mL
    Buffer
    Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Minimize freezing and thawing.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
  • Target
    c-Rel (REL proto-oncogene (c-Rel))
    Andere Bezeichnung
    REL (c-Rel Produkte)
    Synonyme
    C-Rel antikoerper, c-Rel antikoerper, NFkB antikoerper, c-rel antikoerper, zgc:100833 antikoerper, Xrel2 antikoerper, Xrel3 antikoerper, rel antikoerper, rel-A antikoerper, rel2 antikoerper, rel3 antikoerper, v-rel antikoerper, xrel antikoerper, REL proto-oncogene, NF-kB subunit antikoerper, reticuloendotheliosis oncogene antikoerper, RELA proto-oncogene, NF-kB subunit antikoerper, v-rel avian reticuloendotheliosis viral oncogene homolog antikoerper, v-rel avian reticuloendotheliosis viral oncogene homolog L homeolog antikoerper, ribonuclease A family member 2 pseudogene antikoerper, REL antikoerper, Rel antikoerper, Rela antikoerper, rel antikoerper, rel.L antikoerper, ECRP antikoerper
    Hintergrund
    REL, v-rel reticuloendotheliosis viral oncogene homolog (avian), C-Rel, C-Rel proto-oncogene protein, oncogene REL, avian reticuloendotheliosis, v-rel avian reticuloendotheliosis viral oncogene homolog, v-rel reticuloendotheliosis viral oncogene homolog
    Gen-ID
    5966
    NCBI Accession
    NP_002899
Sie sind hier:
Kundenservice